Oral Fluid Drug Test (AS/NZS 4760:2019) – OFT7 Microscreen

55The MicroScreen^™ OFT7 integrates sample collection and immunoassay screening into one, easy-to-use device. This multi-drug screening test is increasingly favoured by Australian providers for drug testing. This non-invasive method analyses saliva samples for parent drugs or their metabolites, assessing impairment at the moment of testing. Onsite testing with the MicroScreen OFT7 delivers rapid results, enabling negative donors to swiftly return to their duties. Non-negative results necessitate laboratory analysis to identify the specific substance and its concentration. 

Key Features

• Convenient and easy to use  - Requires minimal saliva, making it a quick and efficient drug testing solution. Ideal for users with dry mouths and dry worksite conditions.
• Clear and quick results  - Strong test lines provide quick, clear results—no more worrying about faint negatives. Results are ready in under 5-10 minutes. 
• Versatile - The oral fluid test is a convenient, versatile solution that can be administered anytime, anywhere due to its non-invasive nature.

The MicroScreen OFT7 oral fluid drug screening device provides immunoassay screening for seven drugs of abuse:

• Cocaine (COC) 50ng/mL
• Opiates (OPI)  50ng/mL
• Cannabis (THC) 15ng/mL
• Amphetamines (AMP) 50ng/mL
• Benzodiazepine (BZO) 10ng/mL
• Methamphetamines (MET) 50ng/mL
• Oxycodone (OXY)  40ng/mL